Hereditary spastic paraplegia (HSP) is a progressive upper-motor neurodegenerative disease. The eighth HSP locus, SPG8, is on chromosome 8p24.13. The three families previously linked to the SPG8 locus present with relatively severe, pure spastic paraplegia. We have identified three mutations in the KIAA0196 gene in six families that map to the SPG8 locus. One mutation, V626F, segregated in three large North American families with European ancestry and in one British family. An L619F mutation was found in a Brazilian family. The third mutation, N471D, was identified in a smaller family of European origin and lies in a spectrin domain. None of these mutations were identified in 500 control individuals. Both the L619 and V626 residues are strictly conserved across species and likely have a notable effect on the structure of the protein product strumpellin. Rescue studies with human mRNA injected in zebrafish treated with morpholino oligonucleotides to knock down the endogenous protein showed that mutations at these two residues impaired the normal function of the KIAA0196 gene. However, the function of the 1,159-aa strumpellin protein is relatively unknown. The identification and characterization of the KIAA0196 gene will enable further insight into the pathogenesis of HSP.
Hereditary spastic paraplegia (HSP) has a worldwide prevalence of 1-18 in 100,000 [1] [2] [3] and is characterized by central-motor-system deficits leading to lower-limb spastic paraperesis. [4] [5] [6] This is due to a "dying back" phenomenon whereby upper motor neurons degenerate progressively, commencing with the longest axons. 7, 8 HSP can be classified into pure and complicated forms. 5 In pure HSP, lower-limb spasticity is the only major symptom. Alternatively, in complicated HSP, this spasticity can be accompanied by other neurological or nonneurological symptoms, such as ataxia, dementia, mental retardation, deafness, epilepsy, ichthyosis, retinopathy, ocular neuropathy, and extrapyramidal disturbances. 5, 9 There is clinical heterogeneity within families, where age at onset and severity can differ markedly; between families that map to the same locus; and certainly between families that map to separate loci. This heterogeneity complicates genotypephenotype correlations for HSP.
HSP is also extremely genetically heterogeneous. From 130 loci mapped (SPG1-33), 11 genes have been identified. This disease can be transmitted in a dominant (13 loci), a recessive (15 loci), or an X-linked manner (4 loci). [9] [10] [11] By far, the most common locus for the disease is SPG4 (MIM 604277), with mutations in the microtubule-severing protein spastin accounting for ∼40% of dominant HSP cases. 12, 13 Families that map to SPG8 are considered to have one of the more aggressive subtypes of HSP, with disease onset occurring for patients as early as their 20s or 30s. It was first identified in a white family as a 6.2-cM region between markers D8S1804 and D8S1774. 14 The family had 15 patients affected with spasticity, hyperreflexia, extensor plantar reflexes, lower-limb weakness, decreased vibration sensation, and limited muscle wasting. The candidate region was further reduced to 3.4 cM because of a lower recombinant in a second family, which narrows the interval between markers D8S1804 and D8S1179. 15 This family, as well as a third Brazilian family linked to SPG8, also presented with pure adult-onset HSP. 16 For two of the families, a muscle biopsy was performed 14, 16 ; however, no gross histological or histochemical abnormalities were observed. Ragged red fibers have been observed in muscle biopsies of patients with HSP who have paraplegin mutations. 17 In the present study, we identified four additional families that are linked to the SPG8 locus. Genes were screened in an expanded candidate SPG8 locus defined by these four families, along with the British and Brazilian families described above. 15, 16 This led to the identification of three point mutations in the KIAA0196 gene encoding the strumpellin protein product.
Material and Methods

Subjects
Protocols were approved by the Ethics Committee of the Centre Hospitalier de l'Université de Montréal. Patients gave informed consent, after which patient information and blood was collected. DNA was extracted from peripheral blood through use of standard protocols.
Genotyping and Locus Exclusion
PCR-amplified fragments incorporating a-35 S-2-deoxyadenosine 5-triphosphate were resolved on 6% denaturing polyacrylamide gels. Alleles were run alongside an M13mp18 sequence ladder and were scored on the basis of allele sizes and frequencies from the Fondation Jean Dausset-CEPH database. LOD-score calculations and multipoint analysis were performed using the MLINK program of the LINKMAP software package. 18 
Mutation Screening
The 28 exons of KIAA0196 were screened by automated sequencing, including at least 50 bp of each intronic region. Primers were designed using the PrimerSelect program (Lasergene) and were synthesized by Invitrogen Canada. Primer sequences and amplification conditions for each exon are listed in table 1.
Variants were first tested in 12 control individuals by sequencing, followed by allele-specific oligomerization (ASO). 19, 20 In brief, 4 ml of PCR product was hybridized onto Hybond-Nϩ Nylon membranes (Amersham Biosciences) by use of a dot-blot apparatus. P 32 -labeled probes specific to the mutation or normal sequence were hybridized and then visualized on autoradiographic film after overnight exposure. ASO primers for exon 11 are 5 -ACTAGAAAACCTTCAAGCT-3 (normal) and 5 -ACTAGAAGACC-TTCAAGCT-3 (mutated). For exon 14, ASO primers of 5 -GGAGA-GTTGGTATC-3 (normal) and 5 -GGAGAGTTCGTATC-3 (mutated) were used. Exon 15 ASO primers were 5 -CACTGAAGGTT-TTG-3 (normal) and 5 -CACTGAAGTTTTTG-3 (mutated).
Protein-Sequence Alignment
Cluster analysis was performed using the Probcons (v. 1.09) program. Proteins from aligned species included Homo sapiens (Q12768), Canis familiaris (GenBank accession number XP_ 532327), Pan troglodytes (GenBank accession number XP_519952), Drosophila melanogaster (GenBank accession number CG12272), Caenorhabditis elegans (GenBank accession number CE13235), Xenopus tropicalis (GenBank accession number MGC89323), Rattus norvegicus (GenBank accession number XP_343250), Danio rerio (GenBank accession number BC045490), Gallus gallus (GenBank accession number XP_418441), Dictyostelium discoideum (GenBank accession number EAL63144), and Mus musculus (GenBank accession number NP_705776.2).
Homology Modeling
The size of the strumpellin protein (1,159 aa) made it prohibitive to obtain a template for the entire protein. Instead, 200 aa (amino acids 501-725) around the two mutations were selected and inputted in the Phyre program version 2.0 (Phyre Protein Fold Recognition Server). The template with the highest score was selected-namely, 1dn1b from the Neuronal-Sec1 syntaxin 1a complex. The SwissProt database viewer (v. 3.7) 21 was used to visualize the model, with concentration on the a-helix in which the two mutations lie and on a second a-helix in nearby 3D space. Peptides incorporating one or the other identified point mutation were visualized in the same manner.
Expression Studies
Northern-blot and RT-PCR analyses.-The KIAA0196 cDNA pBluescript clone was kindly provided by the Kazusa DNA Research Institute. A 1-kb probe specific to the C-terminal region of strumpellin was generated by digesting the KIAA0196 pBluescript vector with XhoI and NotI. Thirty micrograms of total RNA per sample was loaded. RNA was extracted from various regions of the brain of a control individual. An RT-PCR was performed using Moloney murine leukemia virus-reverse transcriptase (Invitrogen). Primers in exons 10 (forward) and 15 (reverse) of KIAA0196 were used. Glyceraldehyde-3-phosphate dehydrogenase cDNA was amplified as a control.
Constructs
Each mutation was introduced into the KIAA0196 pBluescript clone by site-directed mutagenesis through use of the primers 5 -CTGGAGAGTTCGTATCCTATGTG-3 for the exon 14 variant and 5 -CCTATGTGAGAAAATTTTTGCAGATC-3 for the exon 15 variant, along with primers of their complementary sequence. Wildtype and mutant KIAA0196 cDNAs were cloned, upstream of Myc and His tags, into a pCS2 vector and were transcribed in vitro by use of the SP6 mMESSAGE mMachine kit (Ambion) for zebrafish studies. The protein expression from each of these constructs was validated after their transient expression in cell (HeLa) culture and subsequent western-blot analysis with an anti-Myc antibody. A band at the appropriate height (∼134 kDa for strumpellin) was observed.
Zebrafish Knockdown Studies
Morpholino injections.-Wild-type zebrafish were raised and mated as described elsewhere. 22 Antisense morpholinos (AMOs) were purchased from Genetools. The morpholino sequences were designed against the zebrafish strumpellin ortholog BC045490. The oligonucleotide CTCTGCCAGAAAATCAC(CAT)GATG (KIAA MO) binds to the ATG of the KIAA0196 gene, which prevents its translation, and CTCTcCCAcAAAATgAg(CAT)cATG (CTL MO) is a 5-bp mismatch control. AMO injections were performed as described elsewhere, at a concentration of 0.8 mM. 23 The rescue injections were performed as mentioned above, with morpholino and mRNA concentrations of 0.8 mM and 50 ng/ml, respectively.
Immunohistochemistry.-Standard protocols were used for immunohistochemistry. 22 In brief, 3-d-old embryos were fixed in 4% paraformaldehyde, were washed, and were blocked at room temperature. Primary antibody (anti-acetylated tubulin; 1:50 [Sigma]) was added overnight. After extensive washing, the embryos were incubated with the fluorescently labeled secondary antibody Alexa 568 (Molecular Probes). Imaging was performed on an UltraView LCI confocal microscope (Perkin Elmer) with use of Methamorph Imaging software (Universal Imaging). The statistical significance between the different conditions was calculated using a x 2 test. 
Results
Clinical Information and Family Details
Family FSP24 with the SPG8 mutation is from British Columbia. It is composed of 13 members affected with a spastic gait and lower-limb stiffness (fig. 1A) ; genetic information is available for 10 of them. Symptoms were first observed in individuals between ages 35 and 53 years. Intrafamilial phenotypic heterogeneity exists, as shown by the symptoms presented and the range of disease severity in patients. Deep-tendon reflexes were brisk or increased, and decreased vibration sensation was also noted in three patients. Occasional bladder-control problems were also observed. Walking aids were required for some individuals, whereas one is confined to a wheelchair. Together, these features are consistent with a pure, uncomplicated HSP similar to that described for other families linked to the SPG8 locus. Family FSP29 is of European descent and resides in the United States. There are 31 affected individuals in the family, and genetic information is available for 10 of them ( fig. 1B ). Age at onset was quite variable, with symptom onset ranging in patients from their 20s to their 60s. The family was negative for mutations in the spastin gene.
Linkage Analysis
Two large families that map to the SPG8 locus were identified. In family FSP24, seven markers spanning the candidate region from markers D8S586 to D8S1128 were genotyped in the 18 individuals studied ( fig. 1A) D8S1804, which defined the proximal border of the locus in this family. A lower recombinant was neither identified nor searched for, since the haplotype extended beyond the limits of the SPG8 locus. The maximum LOD score for this family was 3.43 at , by use of CEPH allele frev p 0 quencies for the marker D8S1804, along with a maximum multipoint of 4.20 at marker D8S1799.
The same seven markers tested in family FSP24 were genotyped for family FSP29. A disease haplotype was established for all 10 studied affected individuals; it included many informative recombination events. The proximal recombinant occurred between markers D8S1799 and D8S1832 in three affected individuals ( fig. 1B) , and the distal recombinant was between markers D8S1774 and D8S1128 for another affected individual ( fig. 1B ). This yielded a candidate interval of 3.15 Mb. The maximum LOD score for this family was 5.62 ( ) for marker v p 0 D8S1179 when CEPH allele frequencies were used. Multipoint analysis was also conducted for this family in this region, which yielded a maximum LOD score of 6.73, 0.5 cM centromeric to the D8S1128 marker.
Gene Screening
The previously published SPG8 locus spanned 3.4 cM (1.04 Mb) between markers D8S1804 and D8S1179 on chromosome 8q23-8q24. We screened nine known genes surrounding this candidate region, as annotated in the University of California-Santa Cruz Genome Browser (UCSC) May 2004 update, along with many clustered ESTs and mRNAs that aligned to the locus, without detecting a mutation. Therefore, we opted to redefine the candidate region on the basis of the critical interval determined by an upper recombinant in our FSP29 family at marker D8S1832, and a lower recombinant at D8S1774 was based on published data ( fig. 2A). 14 This increased the size of the region to 5.43 cM (3.15 Mb), a region that contains three additional known genes ( fig. 2B ). These additional genes were screened, and three mutations were identified in the KIAA0196 gene ( fig. 2C ).
Mutation Analysis
A valinerphenylalanine mutation was identified in amino acid 626 for families FSP24 and FSP29 (p.V626F) (fig. 3A) . All studied affected individuals from each family were screened and were positive for this mutation. The same mutation was also found to segregate in a British family. 15 This GrT nucleotide change is at position 1956 of the mRNA (GenBank accession number NM_014846.2). A total of 500 ethnically matched control individuals (400 from North America and 100 from CEPH) were negative for this mutation, on screening by a combination of ASO and sequencing. No unaffected members or spouse control individuals in any family were positive for the mutations.
A second mutation was identified in the Brazilian family 16 in exon 14, a GrC transition at position 1937 of the mRNA (fig. 3B ). This leucinerphenylalanine change (p.L619F) is only 7 aa away from the V626F mutation. It was not found, with use of ASO, in 500 controls.
The KIAA0196 gene was screened in probands from 24 additional dominant HSP-affected families that are negative for mutations in both spastin and atlastin, resulting in the identification of two more families with missense mutations in the KIAA0196 gene. Thus, the frequency of mutations in our SPG3A-and SPG4-negative autosomal dominant cohort is ∼8% (2 of 24). FSP34 has the same p.V626F change in its three affected studied family members. This family is originally from Great Britain and resides in Canada (fig. 1C ). Haplotype analysis of this family with markers D8S1804, D8S1179, D8S1774, and D8S1128 indicated that there is allele sharing between this family and family FSP29, which suggests an ancestral haplotype (table 2 ). An additional mutation was found in three affected siblings of another North American family of European origin, family FSP91 ( fig. 1D ). This c.A1491G transition results in an asparagineraspartate amino acid change (p.N471D) and is not present in the 500 controls tested ( fig. 3C ).
Mutated amino acids at positions 619 and 626 are strictly conserved across all 11 examined species, from human to the social amoeba, D. discoideum ( fig. 3D) . Indeed, the entire region surrounding these two mutations appears to be functionally relevant for the protein, since 73 consecutive aa (amino acids 576-649) are 100% identical in the human, dog, chicken, mouse, rat, and orangutan. Despite this high level of conservation, this region is an unknown domain, on the basis of searches of the National Center for Biotechnology Information (NCBI) Conserved Domain Database, NCBI BLAST, and the Sanger Institute's Pfam database. Position 471 is conserved across all species except D. melanogaster (with a glutamine residue) and X. tropicalis (with a histidine residue).
The exon 15 mutation is in the very first nucleotide of the exon, which leads to the speculation that the splicing of this exon might be compromised in our study families. Splice-site prediction programs, including NetGene2, suggested that the strength of the splice-site acceptor may be reduced by 33% in the mutant form. However, both normal and mutant alleles were observed in cDNA analysis, with use of several pairs of primers, of patient lymphoblasts. The KIAA0196 gene was expressed ubiquitously, including all regions of the brain that were examined by RT-PCR ( fig. 3E ). There were no alternative splice isoforms detected in control brain samples or patient whole-blood samples by RT-PCR and northern-blot analysis ( fig. 3E  and 3F ). For the full KIAA0196 gene, all spliced ESTs and mRNAs from the UCSC browser, May 2004 draft, were analyzed for potential alternative splice products. One alternative first exon often appears; however, of the 356 entries, only 2 (AK223628 and DA202680) contain exons that are skipped. Thus, overall, the gene is not frequently spliced, and the two spliced entries may represent spurious transcripts. A, Gross morphological features of normal wild-type zebrafish, depicted at 3 dpf. B, Injection of a 5-bp mismatch morpholino (CTL MO), which results in no obvious disease phenotype. C and D, KIAA MO-injected fish with a severely curly tail (C) or with a slightly curly tail (D). Their heart cavities are also enlarged, which is commonly seen in injected fish. E and F, Fish, injected with both KIAA MO and normal human KIAA0196 mRNA, with partially developed curly tail (F) or no effect at all (E), depending on the injected quantity. 
KIAA0196 Profile
The KIAA0196 gene spans 59.7-kb pairs of genomic DNA, is 28 exons long, and codes for a protein of 1,159 aa (strumpellin). The European Bioinformatics Institute's InterProScan program predicts a spectrin-repeat-containing domain in amino acids 434-518. Thus, the mutation at position 471 may abrogate the binding of the spectrin domain with other spectrin-repeat-containing proteins. In examination of the secondary structure by use of PSI-PRED, 24 74% of the protein is considered to be a-helical. The program further predicts an a-helix in the protein from amino acids 606-644, which encompasses the two other mutations that have been identified.
Homology Modeling
Given the high proportion of KIAA0196 considered to be a-helical, it is not surprising that the optimal homologymodeling candidates are similar in secondary-structure composition. This is true for 1dn1b, a stat-like t-SNARE protein neuronal-Sec1 syntaxin 1a complex. This is the most appropriate model for strumpellin, according to the Phyre program (Phyre Protein Fold Recognition Server). The two mutated residues lie within an a-helix from amino acids 619-628 that is in close 3D proximity to another a-helix from residues 665-670 ( fig. 4A) . A mutation in either Val-626 or Leu-619 to a phenylalanine residue would appear to have significant structural implications, given the change in bulkiness between the residues. In addition, Tyr-622 points in the same direction from the a-helix residue. To have two amino acids with aromatic rings in such a physical proximity could force apart the alignment of the two ahelices or induce alterations in the a-helix backbone. The N471D mutation was identified well after the two other mutations and so was not tested in homology modeling or in subsequent zebrafish-rescue experiments.
Zebrafish-Rescue Experiments
To validate the functional phenotype of the SPG8 mutations in vivo, we developed a zebrafish model. Morpholino oligonucleotide knockdown of the KIAA0196 protein ortholog in zebrafish (KIAA MO) resulted in an enlarged heart cavity, along with a curly-tail phenotype that severely impaired the ability of the fish to swim properly. The overall phenotype ranged in severity and was classified in three major groups: normal, slightly curly, and severely curly. This phenotype was clearly visible after dechorionating by 1 d post fertilization (dpf). At 3 dpf, wildtype zebrafish are ∼5 mm long, with a straight tail ( fig.  5A ). Fish injected with a mismatch-control morpholino (CTL MO) were initially used to titer a KIAA MO-specific nontoxic injection dose ( fig. 5B) . Injection of the KIAA MO resulted in 66 (37%) of 178 fish with a severely curly tail and 50 (28%) of 178 fish with a slightly curly tail (table  3 and fig. 5C and 5D ). The KIAA MO fish had a significantly different distribution of phenotypic groups compared with those with CTL MO injections ( ). When P ! .001 wild-type human KIAA0196 mRNA was coinjected with KIAA MO, the curly-tail phenotype was rescued to levels comparable to CTL MO injections ( ) ( fig. 5E and P p .51 5F). This suggests that, in zebrafish, human KIAA0196 mRNA can compensate for the loss of endogenous zebrafish mRNA. Conversely, coinjection of human KIAA0196 mRNA incorporating either the exon 14 or exon 15 mutation failed to significantly rescue the phenotype ( fig. 5G  and 5H ). Injection of mutant exon 14 or exon 15 mRNA alone (without morpholinos) did not lead to a curly-tail phenotype or influence lethality in zebrafish, which suggests that the two mutations do not exert a dominant negative effect. Approximately 200 embryos were injected per experimental condition (table 3) . The difference in distribution between KIAA MO injection alone and KIAA MO coinjection with wild-type mRNA was significant ( ). Similarly, coinjection of wild-type mRNA versus P ! .001 either exon 14 or exon 15 mutant mRNA was significantly different, with a P value !.001. There was no statistical difference between the coinjection of the exon 14 mutant and the exon 15 mutant ( ). On histochemical anal-P p .10 ysis of the embryos by use of an antiacetylated tubulin stain for growing axons, we found that the motor neurons in the spinal cord did not develop normally ( fig. 6 ). Motorneuron axons in fish injected with KIAA MO alone or with the mutant mRNAs were shorter and showed abnormal branching. The structure of interneurons in the spinal cord was also different. The absence of the KIAA0196 gene or mutations in this gene during early development thus seemed to hamper axonal outgrowth.
Discussion
HSP is one of the most genetically heterogeneous diseases, caused by mutations in at least 31 different genes. This means that 10.1% of genes in the human genome can be mutated and result in one predominant neurological outcome: the degeneration of upper-motor-neuron axons. Four families in this study share the same p.V626F mutation, which suggests that the altered nucleotide is a mutation hotspot. For one of these families, 15 the KIAA0196 gene lies just beyond its distal candidate boundary. However, the flanking marker likely represents either a marker mutation or genotyping error in this family, since the p.V626F mutation is present in the supposed recombinant as well as all other affected individuals.
An SPG8 mutation causes a pure form of HSP with relatively little interfamilial variability in phenotype. Interestingly, two missense mutations were identified in highly conserved amino acids in a predicted a-helix. The helix consists of a heptameric repeat, with hydrophobic residues aligning in inaccessible regions at the center of the helix. The hydrophobic lysine and valine amino acids are 7 aa apart in the protein sequence; thus, it is expected that they would be buried in the helix, close in 3D space ( fig.  5A) . When replaced by a bulky phenylalanine residue at either position, the stability of the a-helix could very well be disrupted.
The one known domain in strumpellin is a spectrin repeat that consists of three a-helices of a characteristic length wrapped in a left-handed coiled coil. 25 These spectrin repeats appear in the spectrin/dystrophin/a-actinin family. The spectrin proteins have multiple copies (15) (16) (17) (18) (19) (20) of this repeat, which can then form multimers in the cell. Spectrin also associates with the cell membrane via spectrin repeats in the ankyrin protein. Likewise, four spectrin repeats are found in a-actinin beside two N-terminal calponin homology domains that anchor the complex to actin. 26 This effectively connects the cell membrane with the actin-cytoskeletal network. The stability and structure of this network also provide appropriate routes for intracellular vesicular transport, a mechanism already linked to other mutated HSP genes. Proteins with three or fewer spectrin repeats can be considered to have transient association with the spectrin network. The single repeat in strumpellin is more likely to be involved in docking with one of the cytoskeletal spectrin repeats, which could help in protein localization or signal transduction. It will be interesting to determine with which protein(s) strumpellin interacts through its spectrin domain and, particularly, how the mutation identified at the core of this domain influences this potential interaction.
Proteins with a spectrin repeat have been identified in other neurological disorders-most notably, dystrophin, mutated in myotonic dystrophy (MIM 300377). 27 The repeat also has been found in a form of cerebellar ataxia (MIM 117210). 28 b-III spectrin itself is found to be mutated in spinocerebellar ataxia 5. 29 Whereas none of the genes mutated in HSP have a spectrin domain, L1CAM (SPG1) has an indirect association. 9, 30 L1CAM is a single-pass transmembrane protein with a glycosylated extracellular component that facilitates the outgrowth and migration of neurons in the corticospinal tract. The intracellular Cterminus, however, binds to the spectrin-repeat-containing protein ankyrin that links the cell membrane to intracellular spectrin. Thus, strumpellin, with its spectrin domain, may also be involved in this process.
The only detail known so far about the human KIAA0196 gene is that it has previously been implicated in prostate cancer. 31 An increase in gene-copy number was assayed by real-time quantitative PCR and FISH, which determined 110-fold overexpression of the gene in PC-3 prostate cancer lines and in approximately one-third of advanced prostate cancers examined. 31 How this relates to a spastic paraplegia phenotype is not clear.
Analysis of other species has provided some insight into a potential function for KIAA0196. A 118-kDa homologue of the strumpellin protein was identified as part of a TATAbinding protein-related factor 2 (TRF2) complex in a Drosophila nuclear extract. 32 Eighteen proteins were pulled down, along with TRF2, in this complex, including NURF and SWI, with functions for chromatin remodeling and transcription activation. TRF2 is selective for promoters lacking TATA or CAAT boxes. One protein of the complex is DREF, which binds to DRE elements common in controlling genes involved in cell-cycle regulation and cell proliferation. 33, 34 With little known about the function of KIAA0196, we decided to test the functionality of the missense changes with a zebrafish knockdown model. Interestingly, the KIAA MO-injected fish showed a severe tail phenotype characterized by abnormal motor-neuron outgrowth in the spinal cord. The knocked-down zebrafish resembles other mutants affecting midline development. 35 Injection of wild-type human KIAA0196 mRNA concurrently with zebrafish KIAA MO knockdown rescued the phenotype to values not significantly different from a control morpholino injection. However, coinjecting human KIAA0196 mRNA containing either the exon 14 or the exon 15 mutation yielded a phenotype comparable to injection of KIAA MO alone. These experiments demonstrate the importance of the KIAA0196 gene in early development of zebrafish and suggest that the two missense mutations impair the normal function of strumpellin. Further characterization of the KIAA0196 knockdown phenotype is necessary to better understand the role of this gene in early fish development-more precisely, in motor-neuron outgrowth. This phenotype is remarkably similar to what was recently observed in SPG4 morpholino knockdown experiments in the zebrafish 36 : motor-neuron-axon out-growth is impaired, and embryos also have a curly tail. This is another instance in which a dominant adult-onset disease in humans displays an embryonic phenotype in the zebrafish. It can be hypothesized that a complete knockdown of either SPG4 or SPG8 yields an embryonic phenotype, whereas one copy of the gene is enough in humans to remain at a subphenotypic state until adult stages. Importantly, in both instances, it is the motor neurons that are impaired. The identification of KIAA0196 as the gene mutated in SPG8 adds another component to the various genes already identified for the disease. Two missense mutations in a conserved part of the protein have been identified, including one mutation common to four families. Additional work will aid in clarifying the function of the protein and how it relates to other proteins implicated in HSP and the overall disease pathogenesis. As more of the genes involved in HSP emerge, the responsible pathways and mechanisms of toxicity will be better understood. This will also help in elucidating the pathophysiology of a related disease-amyotrophic lateral sclerosis-in which the reduced life span of patients complicates the cloning of genes by linkage analysis.
